117 related articles for article (PubMed ID: 19527222)
1. Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases.
Sexton DJ; Chen T; Martik D; Kuzmic P; Kuang G; Chen J; Nixon AE; Zuraw BL; Forteza RM; Abraham WM; Wood CR
Biochem J; 2009 Aug; 422(2):383-92. PubMed ID: 19527222
[TBL] [Abstract][Full Text] [Related]
2. Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.
Pizard A; Richer C; Bouby N; Picard N; Meneton P; Azizi M; Alhenc-Gelas F
Biol Chem; 2008 Jun; 389(6):701-6. PubMed ID: 18627303
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-dependent expression of the tissue kallikrein gene (Klk1) in the mouse uterus and its implications for endometrial tissue growth.
Rajapakse S; Yamano N; Ogiwara K; Hirata K; Takahashi S; Takahashi T
Mol Reprod Dev; 2007 Aug; 74(8):1053-63. PubMed ID: 17219431
[TBL] [Abstract][Full Text] [Related]
4. Tissue kallikrein regulates alveolar macrophage apoptosis early in influenza virus infection.
Magnen M; Gueugnon F; Petit-Courty A; Baranek T; Sizaret D; Brewah YA; Humbles AA; Si-Tahar M; Courty Y
Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1127-L1140. PubMed ID: 30908937
[TBL] [Abstract][Full Text] [Related]
5. Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins.
Dedio J; Wiemer G; Rütten H; Dendorfer A; Schölkens BA; Müller-Esterl W; Wohlfart P
Biol Chem; 2001 Oct; 382(10):1483-90. PubMed ID: 11727832
[TBL] [Abstract][Full Text] [Related]
6. Kallistatin ameliorates influenza virus pathogenesis by inhibition of kallikrein-related peptidase 1-mediated cleavage of viral hemagglutinin.
Leu CH; Yang ML; Chung NH; Huang YJ; Su YC; Chen YC; Lin CC; Shieh GS; Chang MY; Wang SW; Chang Y; Chao J; Chao L; Wu CL; Shiau AL
Antimicrob Agents Chemother; 2015 Sep; 59(9):5619-30. PubMed ID: 26149981
[TBL] [Abstract][Full Text] [Related]
7. Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion.
Ma L; Wu J; Zheng Y; Shu Z; Wei Z; Sun Y; Carrell RW; Zhou A
Biomolecules; 2020 May; 10(6):. PubMed ID: 32481593
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid blocks porcine pancreatic elastase (PPE)-induced bronchoconstriction in sheep.
Scuri M; Abraham WM; Botvinnikova Y; Forteza R
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1855-9. PubMed ID: 11734436
[TBL] [Abstract][Full Text] [Related]
9. Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease.
Abraham WM; Scuri M; Farmer SG
Eur J Pharmacol; 2006 Mar; 533(1-3):215-21. PubMed ID: 16455073
[TBL] [Abstract][Full Text] [Related]
10. High-throughput affinity ranking of antibodies using surface plasmon resonance microarrays.
Wassaf D; Kuang G; Kopacz K; Wu QL; Nguyen Q; Toews M; Cosic J; Jacques J; Wiltshire S; Lambert J; Pazmany CC; Hogan S; Ladner RC; Nixon AE; Sexton DJ
Anal Biochem; 2006 Apr; 351(2):241-53. PubMed ID: 16510109
[TBL] [Abstract][Full Text] [Related]
11. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.
Chao J; Shen B; Gao L; Xia CF; Bledsoe G; Chao L
Biol Chem; 2010 Apr; 391(4):345-55. PubMed ID: 20180644
[TBL] [Abstract][Full Text] [Related]
12. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
13. Experimental rhinovirus infection increases human tissue kallikrein activation in allergic subjects.
Christiansen SC; Eddleston J; Bengtson SH; Jenkins GR; Sarnoff RB; Turner RB; Gwaltney JM; Zuraw BL
Int Arch Allergy Immunol; 2008; 147(4):299-304. PubMed ID: 18617749
[TBL] [Abstract][Full Text] [Related]
14. The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins.
Santos JA; Kondo MY; Freitas RF; dos Santos MH; Ramalho TC; Assis DM; Juliano L; Juliano MA; Puzer L
Bioorg Med Chem Lett; 2016 Mar; 26(5):1485-9. PubMed ID: 26848109
[TBL] [Abstract][Full Text] [Related]
15. Post-secretory fate of host defence components in mucus.
Salathe M; Forteza R; Conner GE
Novartis Found Symp; 2002; 248():20-6; discussion 27-37, 277-82. PubMed ID: 12568486
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma.
Boudousquié C; Pellaton C; Barbier N; Spertini F
Clin Exp Allergy; 2009 Sep; 39(9):1415-26. PubMed ID: 19624523
[TBL] [Abstract][Full Text] [Related]
17. Inhibition profiles of human tissue kallikreins by serine protease inhibitors.
Luo LY; Jiang W
Biol Chem; 2006 Jun; 387(6):813-6. PubMed ID: 16800745
[TBL] [Abstract][Full Text] [Related]
18. Different role of CD30 in the development of acute and chronic airway inflammation in a murine asthma model.
Polte T; Fuchs L; Behrendt AK; Hansen G
Eur J Immunol; 2009 Jul; 39(7):1736-42. PubMed ID: 19544310
[TBL] [Abstract][Full Text] [Related]
19. Leukocytic cell sources of airway tissue kallikrein.
Lauredo IT; Forteza RM; Botvinnikova Y; Abraham WM
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L734-40. PubMed ID: 14660481
[TBL] [Abstract][Full Text] [Related]
20. Prolonged hypotensive effect of human tissue kallikrein gene delivery and recombinant enzyme administration in spontaneous hypertension rats.
Sun H; Zhang L; Wang A; Xue Z
Exp Mol Med; 2004 Feb; 36(1):23-7. PubMed ID: 15031667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]